Randomized controlled trial of azacitidine in patients with the myelodysplastic syndrome: a study of the Cancer and Leukemia Group B.
- Citation:
- J Clin Oncol vol 20 (10) 2429-40
- Year:
- 2002
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Book Volume:
- Parents:
- None
- Children:
- None
- Pharmas:
- Grants:
- CA 31946, CA 33601
- Corr. Author:
- Authors:
- Lewis R Silverman Erin P Demakos Bercedis L Peterson Alice B Kornblith Jimmie C Holland Rosalie Odchimar-Reissig Richard M Stone Douglas Nelson Bayard L Powell Carlos M DeCastro John Ellerton Richard A Larson Charles A Schiffer James F Holland
- Networks:
- Study
- CALGB-9221
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords:
- Adult, Aged, Aged, 80 and over, Antimetabolites, Antineoplastic, Azacitidine, Blood Cell Count, Bone Marrow, Cross-Over Studies, Female, Humans, Injections, Subcutaneous, Leukemia, B-Cell, Male, Middle Aged, Myelodysplastic Syndromes, Remission Induction, Risk Factors, Treatment Outcome